Hats Off to the Recipients of the 2020 ASH Scholar Awards!
The American Society of Hematology (ASH) has announced the 39 recipients of its 2020 Scholar Awards, one of the Society's most prestigious research award programs.
Since 1985, the ASH Scholar Awards have helped ease the transition period between completion of training and the establishment of an independent career for hematology researchers in the U.S. and Canada. Each award provides between $100,000 and $150,000 over 2 to 3 years, dependent on level of experience.
ASH Scholar Awards are made possible through support from the ASH Foundation, as well as from the corporate community, individual donors, and funds committed by the Society. ASH gratefully acknowledges this year's corporate supporters: AstraZeneca, Pharmacyclics LLC, and Daiichi Sankyo, Inc.
"For many scientists, attaining early funding for their research is a turning point, not only providing financial support but also showing that ASH believes in their potential to make impactful discoveries," said 2020 ASH President Stephanie Lee, MD, MPH of Fred Hutchinson Cancer Research Center. "Prior recipients of these prestigious awards have gone on to distinguished careers, receiving more than $1 billion from various funding institutions and becoming leaders in our field."
Congratulations to the 2020 Scholar Awards recipients!
- Benjamin Barwick, PhD, Emory University
- Theodore Braun, MD, PhD, Oregon Health & Science University
- Federico Gaiti, PhD, Weill Cornell Medicine
- Oluwabukola Gbotosho, PhD, University of Pittsburgh
- Robert Lee, PhD, The University of North Carolina at Chapel Hill
- Hojun Li, MD, PhD, Dana-Farber Cancer Institute
- Stephanie Luff, PhD, Washington University
- Satish Nandakumar, PhD, Boston Children's Hospital
- Abhishek Singh, PhD, Cincinnati Children's Hospital Medical Center
- Alexandra Soukup, PhD, University of Wisconsinâ€”Madison
- Julia Warren, MD, PhD, Washington University
- Seongseok Yun, MD, PhD, H. Lee Moffitt Cancer Center & Research Institute
- Patricia Zerra, MD, Emory University
Basic/Translational Fellow to Faculty
- Annamaria Gulla, MD, Dana-Farber Cancer Institute
- Rossella Marullo, MD, PhD, Weill Cornell Medicine
- Idit Sagiv-Barfi, PhD, Stanford University
- Amanda Smith, PhD, Washington University
- Erica Sparkenbaugh, PhD, The University of North Carolina at Chapel Hill
- Anastasia Tikhonova, PhD, New York University School of Medicine
- Ly Vu, PhD, Simon Fraser University
Basic/Translational Junior Faculty
- Michalis Agathocleous, PhD, UT Southwestern Medical Center
- Wendy Beguelin, PhD, Weill Cornell Medicine
- Stephen Chung, MD, UT Southwestern Medical Center
- Shannon Elf, PhD, The University of Chicago
- Hongxia Fu, PhD, University of Washington
- Siddhartha Jaiswal, MD, PhD, Stanford University
- Kellie Machlus, PhD, Brigham and Women's Hospital
- Anjali Mishra, PhD, Thomas Jefferson University
- Andrew Yee, PhD, Baylor College of Medicine
- Hanny Al-Samkari, MD, Massachusetts General Hospital
- Francesco Maura, MD, Sloan Kettering Institute for Cancer Research
- Karolyn Oetjen, MD, PhD, Washington University
- Akshay Sharma, MBBS, St. Jude Children's Research Hospital
Clinical Fellow to Faculty
- Lena Winestone, MD, University of California San Francisco
Clinical Junior Faculty
- David Bartlett, PhD, Duke University
- Patrick McGann, MD, Cincinnati Children's Hospital Medical Center
- Rakhi Naik, MD, Johns Hopkins University
- Jacquelyn Powers, MD, Baylor College of Medicine
- Deborah Siegal, MD, McMaster University
For more information about the ASH Scholar Award or to apply, visit hematology.org/scholar.
Hot Off the Press: New ASH Clinical Practice Guidelines on ITP
The Society is pleased to announce the publication of new ASH Clinical Practice Guidelines in Blood Advances for Immune thrombocytopenia (ITP).
In partnership with the University of Oklahoma Health Sciences Center, ASH has created new evidence-based guidelines for the treatment of ITP in children and adults. The guidelines, which update ITP recommendations published by ASH in 2011, address appropriate corticosteroid use in adults and stress avoiding unnecessary treatment in children. They also tackle the complex decision-making surrounding second-line agents.
These new ITP guidelines "are a trustworthy resource for patient care in that they are the product of a rigorous process that met the highest standards of transparency," said Cindy Neunert, MD, of New York-Presbyterian Hospital, who is chair of the ASH ITP guideline panel. "Our multidisciplinary guidelines panel included both adult and pediatric clinical experts, methodologists with expertise in ITP, and two patient representatives, whose perspectives were extremely valuable in helping us to evaluate the impact of various disease management options on quality of life."
Find the guidelines and additional resources at hematology.org/ITPguidelines.